Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PMAs Buck Trend: Reviews Taking Longer In FY 2001 Than Year Ago

This article was originally published in The Gray Sheet

Executive Summary

Review times for CDRH's modular PMA program have lengthened considerably during fiscal 2001, contributing to a slight rise in overall PMA review times

You may also be interested in...



Device Center Modular PMA Submissions Down In FY 2001

FDA received fewer PMA shells and modules in FY 2001 than in previous years, while the proportion of PMA modules found deficient compared to those found acceptable increased

Device Center Modular PMA Submissions Down In FY 2001

FDA received fewer PMA shells and modules in FY 2001 than in previous years, while the proportion of PMA modules found deficient compared to those found acceptable increased

CDRH Drafts Strategic Game Plan To "Skate Where The Puck Will Be"

The Center for Devices and Radiological Health is considering expanding use of outside experts as one way to help address current and future challenges.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel